CNBX Pharmaceuticals Inc.
CNBX
$0.00
$0.00-20.00%
OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -314.00K | -224.50K | -295.40K | -551.10K | -695.20K |
| Total Depreciation and Amortization | -- | 0.00 | 0.00 | 32.90K | 72.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 39.80K | 56.50K | 42.30K | 202.10K | 245.40K |
| Change in Net Operating Assets | 102.80K | -23.00K | 114.30K | 104.60K | 133.20K |
| Cash from Operations | -171.30K | -191.10K | -138.90K | -211.60K | -244.30K |
| Capital Expenditure | -- | 0.00 | 0.00 | 0.00 | -1.20K |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 94.70K | 114.70K | 114.70K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 0.00 | 94.70K | 114.70K | 113.50K |
| Total Debt Issued | 160.00K | 131.30K | 112.60K | 32.60K | 27.60K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 160.00K | 131.30K | 112.60K | 32.60K | 27.60K |
| Foreign Exchange rate Adjustments | -- | -- | -59.90K | 0.00 | 0.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.30K | -59.80K | 8.50K | -64.30K | -103.20K |